1880 S Dairy Ashford Rd, Suite 650, Houston, TX 77077

Blood Screening Market to Rise at a 11.8% CAGR from 2023 to 2031, Reaching a Value of USD 7.37 Billion


The Blood Screening Market was valued at USD 3.02 billion in 2023. It is projected to reach a valuation of USD 7.37 billion by 2031, experiencing a compound annual growth rate (CAGR) of 11.8% throughout the forecast period from 2024 to 2031.

Blood Screening Market
Blood Screening Market

The high growth trajectory of this market is attributed to factors like rising blood donations, an increase in the incidence of infectious diseases, and government initiatives. According to the World Health Organization (WHO), 118.54 million blood donations are collected globally each year. In the United States alone, 6.8 million individuals donate blood annually, resulting in the collection of 13.6 million units of red blood cells and whole blood annually.

Get Report Sample of Blood Screening Market @ https://www.snsinsider.com/sample-request/3151

List of Blood Screening Companies Profiled in Report:

  • Grifols
  • Hoffmann-La Roche
  • Abbott Laboratories
  • Biomérieux
  • Bio-Rad Laboratories Inc.
  • Siemens Healthineers
  • Ortho Clinical Diagnostics Inc
  • BD
  • DiaSorin S.p.A.

Rising Blood Donations and Transfusions

The increasing number of blood donation drives and surgeries requiring blood transfusions are propelling market growth. For instance, according to a National Library of Medicine article published in December 2021, roughly 234 million major surgeries are performed globally each year. Blood transfusions are frequently needed during childbirth complications, childhood acute anemia, trauma cases, and congenital maternal blood disorders. Additionally, growing blood donation activities are expected to further fuel market expansion.

As per the Joint United Nations Programme on HIV/AIDS (UNAIDS) ‘Global HIV and AIDS Statistics 2021’ fact sheet, approximately 38.4 million people globally were living with HIV in 2021. This widespread presence of infectious diseases necessitates early and effective diagnosis, driving the demand for blood screening tests.

Government Initiatives and Awareness Campaigns

Various organizations and governments are actively promoting blood donation and blood screening before transfusions. For example, “the World Health Organization (WHO) celebrates World Blood Donor Day on June 14th annually to raise global awareness about the need for safe blood and blood products for transfusions”.

Growing strategic collaborations among market players are expected to accelerate the availability of advanced diagnostic tests, consequently bolstering market growth. For instance, “in March 2023, TruDiagnostic, a health data company, partnered with NADMED, a Finnish nicotinamide adenine dinucleotide (NAD) diagnostic company, to introduce a new NAD+ blood diagnostic test for patients in the United States”.

Have Any Query? Ask Our Experts @ https://www.snsinsider.com/enquiry/3151

Blood Screening Industry Segmentation as Follows:

By Product & Service

  • Reagents & Kits
    • NAT Reagents & Kits
      • Enzymes & Polymerases
      • Standards & Controls
      • Probes & Primers
      • Buffers, Nucleotides, and Solutions
      • Labelling & Detection Reagents
    • ELISA Reagents & Kits
      • Immunosorbents
      • Controls
      • Conjugates
      • Substrates
      • Sample Diluents & Wash Solutions
    • Other Reagents & Kits
  • Instruments
    • Rental Purchase
    • Outright Purchase
  • Software & Services

By Technology

  • Nucleic Acid Test
    • Transcription-mediated Amplification
    • Real-time PCR
  • ELISA
    • Chemiluminescent Immunoassays
    • Fluorescent Immunoassays
    • Colorimetric Immunoassays
  • Rapid Tests
  • Western Blot Assays
  • Next-generation Sequencing

By End User

  • Blood Banks
  • Hospitals

Reagent Segment to Hold Significant Market Share

The reagent segment, encompassing chemical, biological, or immunological components used in blood screening processes, is expected to capture a significant market share throughout the forecast period. The COVID-19 pandemic significantly contributed to this segment’s growth due to the high demand for reagents to meet the global diagnostic needs for COVID-19 screening. Additionally, the rising burden of infectious diseases worldwide is expected to fuel the demand for blood screening, consequently increasing the requirement for reagents used in various testing platforms.

Ask For Discount on This Report @ https://www.snsinsider.com/discount/3151

North America to Lead Blood Screening Market Due to High Demand and Advanced Healthcare Systems

The rising healthcare spending fuels the market by enabling the adoption of advanced screening technologies. Additionally, the prevalence of infectious diseases, like HIV, necessitates increased blood screening to ensure transfusion safety. Finally, the highly developed healthcare infrastructure in the US and Canada facilitates widespread blood donation and transfusion practices.

It highlights the huge demand to screen blood in this region, ‘for example.’ The United States alone needs more than 36,000 units of Red Blood Cells every day.

Key Takeaways: Why You Should Purchase This Blood Screening Market Report

  • Gain valuable insights into the blood screening market’s growth trajectory and future potential.
  • Understand the key factors driving the market, including rising blood donations, increasing disease burden, and technological advancements.
  • Explore the market segmentation by product, technology, disease type, and end-user to identify lucrative investment opportunities.
  • Analyze the impact of regional trends, including the dominance of North America and the challenges posed by the Russia-Ukraine war.
  • Stay updated on the latest developments in the market, such as recent product launches and FDA approvals.

Table of Content

Chapter 1 Introduction

Chapter 2 Research Methodology

Chapter 3 Blood Screening Market Dynamics

Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)

Chapter 5 Value Chain Analysis

Chapter 6 Porter’s 5 forces model

Chapter 7 PEST Analysis

Chapter 8 Blood Screening Market Segmentation, By Product & Service

Chapter 9 Blood Screening Market Segmentation, By Technology

Chapter 10 Blood Screening Market Segmentation, By End User

Chapter 11 Regional Analysis

Chapter 12 Company profile

Chapter 13 Competitive Landscape

Chapter 14 Use Case and Best Practices

Chapter 15 Conclusion

Continued…

Purchase Blood Screening Market Report @ https://www.snsinsider.com/checkout/3151

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com/

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.